0

Super eagles goalkeeper, Carl Ikeme has been diagnosed with acute leukaemia

super eagles goalkeeper

Reports gotten from an official statement from Nigeria’s no 1 goalkeeper, Carl ikeme’s English Premiership team, Wolves states that, the 31-year-old Nigerian international goalkeeper returned with some abnormal blood tests during his pre-season testing, and further medical investigation has showed that he is suffering from leukaemia.

According to the statement, Carl will now start an immediate course of chemotherapy as he begins a lengthy battle against the disease. We pray to God to see him through this…
Wolves’ Managing Director Laurie Dalrymple said;
“It would be an understatement to say that everyone at Wolves has been shocked and saddened to hear the news of Carl’s diagnosis. That relates to both players and staff as Carl has been at the club for a very long time and remains such an integral personality within the group.

At the same time, we all know what a fighter and a competitor Carl is, and I have no doubt that he will take all of those attributes into this battle. Similarly, its goes without saying that Carl and his family will receive the full love and support that we at Wolves can provide – we are all with him every single step of the way towards a full recovery.

There are going to be some very tough times ahead, but he will receive the best possible care, aided and supported by our own club doctor and medical team, as he embarks on the lengthy process of treatment.

“We are speaking to Carl regularly, and sending him our very best wishes as he comes to terms with this news and starts his recovery.”

Carl and his family would request that their privacy be respected at this time, and any updates on his progress will be provided through the club.”

NFF President, Amaju Pinnick also confirmed this via his official Twitter handle, asking Nigerians to offer prayers as Ikeme undergoes treatment.
super eagles goal keeper
super eagles goal keeper

imustalk

Leave a Reply

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.